Zepbound® Consultation Program

Zepbound® Consultation Program

Starting at $129

Zepbound® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI and metabolic health criteria. It contains tirzepatide, a next-generation therapy that activates both GLP-1 and GIP receptors, two key pathways involved in appetite regulation, blood sugar control, and metabolic efficiency.

Have Questions? Call Us Free: 888-516-0285

Free membership includes provider access, program support, and member benefits.

Zepbound® Consultation Program

Zepbound® Consultation Program

Starting at $129

Zepbound® is an FDA-approved prescription medication for chronic weight management in adults who meet specific BMI and metabolic health criteria. It contains tirzepatide, a next-generation therapy that activates both GLP-1 and GIP receptors, two key pathways involved in appetite regulation, blood sugar control, and metabolic efficiency.

Free membership includes provider access, program support, and member benefits.

Why Choose Zepbound®?

Zepbound® offers a next-generation approach to medical weight management, designed for individuals who need more than appetite suppression alone. Key reasons patients and providers choose Zepbound include:

  • Dual-hormone action for enhanced results
    Zepbound activates both GLP-1 and GIP receptors, addressing appetite regulation, satiety, and metabolic efficiency through two complementary pathways.

  • FDA-approved for chronic weight management
    Clinically evaluated and approved specifically for long-term weight management in adults who meet BMI and health criteria.

  • Stronger weight-loss potential
    Clinical trials demonstrate average total body weight reductions of up to 20% or more, when paired with nutrition and lifestyle changes.

  • Once-weekly simplicity
    Convenient, at-home subcutaneous injections support consistency without daily dosing or in-office visits.

  • Structured, provider-guided care
    Treatment includes personalized dosing, titration, and clinical oversight to support safety, adherence, and sustainable outcomes.

  • Designed for metabolic alignment
    Beyond appetite control, Zepbound supports insulin signaling and metabolic regulation—key drivers of long-term success.

Through BeyondMD, Zepbound is delivered as part of a medically supervised program focused on precision, accountability, and durable progress.

Zepbound® may be an appropriate option for adults who meet clinical criteria for chronic weight management and are seeking a medically guided approach to sustainable results.

You may be eligible if you have:

  • A BMI of 30 or higher, or

  • A BMI of 27 or higher with at least one weight-related health factor, such as insulin resistance, prediabetes, PCOS, high blood pressure, or abnormal cholesterol levels

Eligibility is not determined by BMI alone. A BeyondMD provider evaluates your medical history, metabolic profile, current medications, and weight-related goals to determine whether Zepbound aligns with your needs.

Some individuals with a BMI between 25–26.9 may be considered on a case-by-case basis when additional metabolic risk factors are present.

Final eligibility is always determined through a licensed provider consultation to ensure safe, personalized, and clinically appropriate care.

The BeyondMD Zepbound® program is built to deliver structure, oversight, and simplicity from start to long-term management. Your program includes:

  • Provider evaluation and prescription (if approved)
    A licensed BeyondMD provider conducts a full clinical review to determine whether Zepbound is appropriate for you.

  • Personalized dosing and titration plan
    A customized escalation schedule designed to support effectiveness while improving tolerability.

  • Ongoing clinical oversight
    Continued access to BeyondMD’s medical team for progress monitoring, dose adjustments, and treatment guidance.

  • Medication coordination and discreet home delivery
    Zepbound is shipped directly to your home through authorized pharmacy partners for convenience and privacy.

  • Optional insurance support
    Complimentary insurance verification available upon request to help clarify coverage and cost expectations.

  • Long-term weight management strategy
    Care is designed to support consistency, metabolic health, and sustainable results—not short-term intervention.

Every element of the program is structured to reduce friction, increase adherence, and support meaningful, lasting progress.

 

Your Treatment Journey

STEP 1

Online evaluation

STEP 2

Approval

STEP 3

Delivery

STEP 4

Multi-peptide protocol + check-ins

Ready to Take Control of Your Nutrition and Energy?

Discover how once-weekly GLP-1 therapy can simplify appetite management and support steady, sustainable change.

Safety & Side Effects

Common experiences can include transient GI symptoms (e.g., nausea, fullness, changes in bowel habits) that often improve with dose titration and meal timing. Your provider will individualize pacing, nutrition strategy, and stacking options.

Extensive human data show GLP-1 therapies improve weight-related outcomes and glycemic control across diverse populations. Effects are optimized when combined with nutrition, resistance training, and sleep consistency.

Simplify Progress. Sustain Results.

Begin your physician-guided GLP-1 program with BeyondMD—personalized dosing, expert oversight, and convenient home delivery.

Frequently Asked Questions About Zepbound®

What is Zepbound®?

Zepbound® is an FDA-approved prescription medication for chronic weight management. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist designed to support appetite regulation, metabolic health, and sustained weight loss when combined with lifestyle changes.

Adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition (such as high blood pressure, type 2 diabetes, high cholesterol, insulin resistance, or PCOS) may qualify. Final eligibility is determined by a licensed provider after clinical review.

Zepbound is administered as a once-weekly subcutaneous injection. It is provided in pre-measured single-dose vials and is intended for at-home use under provider guidance.

Clinical trials have demonstrated up to 20% or more total body weight reduction over time when Zepbound is used consistently alongside a reduced-calorie diet and increased physical activity. Individual results vary.

Treatment begins with a provider consultation. If approved, your FDA-approved medication is coordinated through authorized pharmacy partners and shipped discreetly to your home, with ongoing clinical oversight throughout your program.